Join
Live feed
·
PRReleasevia Quantisnow
Pulse Biosciences Inc logo

Pulse Biosciences Completes Enrollment in the PRECISE-BTN Clinical Study Evaluating the nPulse™ Vybrance™ Percutaneous Electrode System for Symptomatic Benign Thyroid Nodules

ByQuantisnow·Wall Street's wire, on your screen.
PLSE· Pulse Biosciences Inc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PLSE (Pulse Biosciences Inc) and more on Quantisnow.